November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Hidehito Horinouchi: HARMONi-A – Chemo +/- Ivonescimab in EGFRm NSCLC after EGFR-TKIs resistance
Jun 1, 2024, 10:17

Hidehito Horinouchi: HARMONi-A – Chemo +/- Ivonescimab in EGFRm NSCLC after EGFR-TKIs resistance

Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital, recently shared a post on X:

ASCO24 Abstracts

No. 8508 HARMONi-A: Chemo +/- Ivonescimab (AK112/SMT112, anti-PD-1/VEGF bispecific ab) in EGFRm NSCLC after EGFR-TKIs resistance
Presenter: Dr. Li Zhang

  • PFS HR 0.46 (95%CI: 0.34, 0.62),
  • Phase III,
  • Primary PFS,
  • NCT05184712.”

Source: Hidehito Horinouchi/X